| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |